Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection
Clinical trial NCT02765490 · COMPLETED
Trial details
- NCT number
- NCT02765490
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-09
- Primary completion
- 2017-08-09
- Enrollment
- 365
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.